Real-time coverage of inside of the brain made possible

May 1, 2018, Nagoya University
Fig.1 Differences between conventional metabolome analysis for dissected brain samples and the newly developed in vivo real-time monitoring system. Credit: Nagoya University

Real-time monitoring of the dynamics of endogenous molecules in organisms is an important aspect in the study of diseases. However, this process is difficult because of issues such as sensitivity, resolution, and invasiveness. This challenge has become a major motivation for the development of new effective tools for real-time monitoring of analytes of interest.

In their latest study, a team of Nagoya University-centered researchers have successfully found a novel approach for in vivo real-time monitoring of metabolites using a combination of probe electrospray ionization (PESI), a unique ambient ionization technique, and tandem mass spectrometry (MS/MS), a technique for finer characterization of endogenous metabolites within a sample of interest, particularly when the metabolites cannot be identified by single MS. The team reported its study in Analytical Chemistry.

"While the thin probe needle in PESI enables direct sampling with subcellular-level invasiveness, and combinational use of PESI and single mass spectrometry (PESI/MS) has been applied to direct analysis of target compounds, PESI/MS lacks selectivity because PESI does not possess chromatographic separation property," study co-first author Yumi Hayashi says. "Therefore, combinational use with a specific detector such as MS/MS must be explored for reliable identification of metabolites."

The new analytical developed by the team consists of a free-movable stage and a unique probe electrospray ionization-tandem mass spectrometer unit, which uses an extremely thin solid needle (with a tip diameter of about 700 nm) for direct sampling and ionization. The system successfully monitored eight cerebrum metabolites related to central energy metabolism in an isoflurane-anesthetized mouse in real time with a 20-second interval. Notably, neither remarkable traumatic injury nor edema was observed on the brain surface, examined 3 hours after in vivo real-time monitoring.

The newly developed stage is composed of an x-y-z free movable stage, rubber heater, and fixing arm unit. The stage enables control of the sampling point with μm-order spatial resolution. Credit: Kei Zaitsu

To further validate the system, the team applied it to cannabinoid type-1 receptor agonist (CB1R-agonist) administered and control mice brains, and succeeded in capturing the dynamics of energy metabolism. CB1R-agonist has been shown to decrease food intake and regulate body-weight gain.

"The demonstrated capabilities of the new PESI/MS/MS system make it a promising tool for the analysis of neurodegenerative diseases, such as Alzheimer's disease. We can also use it to analyze other tissues such as liver and kidney, suggesting a wide-range applicability of the present system," corresponding author Kei Zaitsu says. "Using this system, we believe a new research field called 'real-time metabolomics' can be explored and expanded."

To further validate the system, the team applied it to cannabinoid type-1 receptor agonist (CB1R-agonist) administered and control mice brains, and succeeded in capturing the dynamics of energy metabolism. CB1R-agonist has been shown to decrease food intake and regulate body-weight gain.

Explore further: Robotics takes mass spec to the third dimension for forensics, pharma applications

More information: Kei Zaitsu et al. In Vivo Real-Time Monitoring System Using Probe Electrospray Ionization/Tandem Mass Spectrometry for Metabolites in Mouse Brain, Analytical Chemistry (2018). DOI: 10.1021/acs.analchem.7b05291

Related Stories

Researchers design upgrade device for mass spectrometers

April 10, 2018

Researchers from Skoltech and MIPT have developed a device for upgrading mass spectrometers used to analyze the chemical makeup of unknown substances. The new device analyzes one substance from four different perspectives. ...

New tool on horizon for surgeons treating cancer patients

June 18, 2015

Surgeons could know while their patients are still on the operating table if a tissue is cancerous, according to researchers from the Department of Energy's Oak Ridge National Laboratory and Brigham and Women's Hospital/Harvard ...

Recommended for you

First microarrayed 3-D neuronal culture platform developed

November 14, 2018

Neuronal development is often regulated by the graded distribution of guidance molecules, which can either attract or repel the neuronal migration or neurite projection when presented in a format of concentration gradients, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.